Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth-Reference-Cited by-同舟云学术

Nanoparticle-based drug delivery via RBC-hitchhiking for the inhibition of lung metastases growth

Published:2019 Issue:4 Volume:11 Page:1636-1646
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Zelepukin I. V.¹²³⁴⁵^ORCID,Yaremenko A. V.¹²³⁴⁵^ORCID,Shipunova V. O.¹²³⁴⁵^ORCID,Babenyshev A. V.¹²³,Balalaeva I. V.⁶⁷³,Nikitin P. I.⁸⁹¹⁰³¹¹^ORCID,Deyev S. M.⁴⁵¹⁰³¹¹^ORCID,Nikitin M. P.¹²³⁴⁵^ORCID

Affiliation:

1. Moscow Institute of Physics and Technology

2. Dolgoprudny

3. Russia

4. Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry

5. Russian Academy of Sciences

6. Lobachevsky State University of Nizhny Novgorod

7. Nizhny Novgorod

8. Prokhorov General Physics

9. Institute of the Russian Academy of Sciences

10. Moscow

11. National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)

Abstract

RBC-hitchhiking regime is shown without prolongation of nanoparticle blood circulation but with the record 120-fold boost of particle delivery to lungs. The approach is efficient for treatment of pulmonary metastases.

Funder

Russian Foundation for Basic Research

Russian Science Foundation

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2019/NR/C8NR07730D

Reference63 articles.

1. Advanced Smart Nanomaterials with Integrated Logic-Gating and Biocomputing: Dawn of Theranostic Nanorobots

2. Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy